Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells.

Annals of hematology - 1 Mar 2011

Kobayashi Shinichi, Sato Ken, Kobayashi Ayako, Osawa Yukiko, Nakamura Yukitsugu, Kimura Fumihiko

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Blast Crisis
Share to Clone Cells
Share to Imatinib Mesylate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Neoplastic Stem Cells

Share to Piperazines

Share to Precursor Cells, B-Lymphoid

Source

Identifiers

PMID: 20556391
DOI: 10.1007/s00277-010-1008-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells.PMID 20556391Read ↗

Pathobiology of lymphoid and myeloid blast crisis and management issues.Semantic proximity Read ↗

Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Semantic proximity Read ↗

The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib TherapySemantic proximity Read ↗

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantationSemantic proximity Read ↗

Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease.Semantic proximity Read ↗

Blast phase of chronic myeloid leukemia presenting lymphoid phenotype with a chronic phase of extremely short duration.Semantic proximity Read ↗

The CML stem cell: Evolution of the progenitorSemantic proximity Read ↗

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.Semantic proximity Read ↗

Extramedullary blast crisis in a chronic myeloid leukaemia patient after achieving a major molecular response with bosutinib.Semantic proximity Read ↗

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administrationSemantic proximity Read ↗

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.Semantic proximity Read ↗

A limited but necessary indication of stem cell transplantation for chronic myelogeneous leukemia in the era of tyrosine kinase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.